These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 25866058)
41. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells. Vachtenheim J; Ondrusová L; Borovanský J Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088 [TBL] [Abstract][Full Text] [Related]
42. A germline oncogenic MITF mutation and tumor susceptibility. Paillerets BB; Lesueur F; Bertolotto C Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354 [TBL] [Abstract][Full Text] [Related]
43. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype. Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089 [TBL] [Abstract][Full Text] [Related]
44. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4. Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610 [TBL] [Abstract][Full Text] [Related]
45. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma. Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292 [TBL] [Abstract][Full Text] [Related]
46. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674 [TBL] [Abstract][Full Text] [Related]
47. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells. De Luca T; Pelosi A; Trisciuoglio D; D'Aguanno S; Desideri M; Farini V; Di Martile M; Bellei B; Tupone MG; Candiloro A; Regazzo G; Rizzo MG; Del Bufalo D Mol Carcinog; 2016 Dec; 55(12):2304-2312. PubMed ID: 26599548 [TBL] [Abstract][Full Text] [Related]
48. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797 [TBL] [Abstract][Full Text] [Related]
49. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967 [TBL] [Abstract][Full Text] [Related]
50. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells. Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927 [TBL] [Abstract][Full Text] [Related]
51. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion. Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954 [TBL] [Abstract][Full Text] [Related]
52. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells. Sestáková B; Ondrusová L; Vachtenheim J Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556 [TBL] [Abstract][Full Text] [Related]
53. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464 [TBL] [Abstract][Full Text] [Related]
55. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma]. Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313 [TBL] [Abstract][Full Text] [Related]
56. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation. Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434 [TBL] [Abstract][Full Text] [Related]
57. MITF in melanoma: mechanisms behind its expression and activity. Hartman ML; Czyz M Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395 [TBL] [Abstract][Full Text] [Related]
58. Negative Regulatory Loop between Microphthalmia-Associated Transcription Factor (MITF) and Notch Signaling. Golan T; Levy C Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699982 [TBL] [Abstract][Full Text] [Related]
59. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity. Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993 [TBL] [Abstract][Full Text] [Related]
60. Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells. Motzik A; Amir E; Erlich T; Wang J; Kim BG; Han JM; Kim JH; Nechushtan H; Guo M; Razin E; Tshori S Oncogene; 2017 Aug; 36(33):4732-4738. PubMed ID: 28394346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]